Roche has announced the US launch of automated Elecsys HE4 assay, designed as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. The assay, which is approved for use on the Elecsys ...
Tags: epithelial ovarian cancer, clinical technology, clinical trial